FDA Issues Warning Letter to Corporate Sponsor of Clinical Trial

Categories: Hi-Tech

The U.S. Food and Drug Administration (FDA) does not frequently issue Warning Letters to corporate sponsors of FDA-regulated clinical trials, so the June 16, 2015, Warning Letter sent to AB Science, a pharmaceutical company with offices in France and New

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C